Equities not available in your region
ABBV icon

AbbVie (ABBV)

NYSE

251,25 $

0,18 $ (

+0,07 %

)

1D
5D
1M
6M
1Y
5Y
Market closed

ABBV: 251,25 $ / ₿ 0.0042 BTC / 418206 Sats

1D
5D
1M
6M
1Y
5Y

Key statistics

251,08 $
184,63 $ - 255,99 $
443,91 G$
-3.77
81,00 $
1,77G
123.07
249,34 $ - 254,70 $
2.76
Yes

What is AbbVie (ABBV)?

AbbVie é uma empresa farmacêutica com forte exposição à imunologia (com Humira, Skyrizi e Rinvoq) e oncologia (com Imbruvica e Venclexta). A empresa foi desmembrada da Abbott no início de 2013. A aquisição da Allergan em 2020 adicionou vários novos produtos e medicamentos na área de estética, incluindo o Botox. As aquisições da Cerevel (neurociência) e da ImmunoGen (oncologia) em 2024 ajudam a complementar o portfólio da AbbVie.

The AbbVie (ABBV) stock price has been rising

The ABBVIE INC. (ABBV) stock price today is 251,25 $, reflecting a +0,07 % move since the market opened. The company’s market capitalization stands at 443,91 G$, with a daily trading volume of 81,00 $ shares. The previous closing price was 251,08 $.

Get started with AbbVie (ABBV)

Ready to get started? Follow the steps below, or read our guide on how to buy AbbVie stock on Kraken starting from $10.

Create an account

Create an account

Open the Kraken app to confirm your eligibility and follow the steps for account verification.



Deposit funds

Deposit funds

Once your account has been verified and stock trading is unlocked, you can deposit funds into your account using your preferred payment method.

Buy

Buy ABBV

Search for ABBV in the Kraken app, enter the amount you want to invest, review the important details and tap Confirm to place an order to buy ABBV.

ABBV FAQs

ABBV is in the Healthcare sector. Sector is a broad classification that groups companies based on their business activities, industry focus or economic function.

ABBV is in the Drug Manufacturers - General industry. Industry is a more specific classification within a sector, grouping companies that operate in a similar field and have closely related business models.

Over the past 52 weeks, ABBVIE INC. (ABBV) has traded between a low of 184,63 $ and a high of 255,99 $.

ABBV is in the Drug Manufacturers industry group. Industry group is a further subdivision within an industry, grouping companies with even more closely related business models and operations. This helps investors analyze stocks at a more detailed level than sector and industry classifications alone.

ABBV’s payout ratio is 3.26. Payout ratio is a financial metric used to measure the proportion of a company's earnings that are paid out as dividends to shareholders.

ABBV’s trailing dividend yield is 2.68. Trailing dividend yield is a financial metric used to measure the return on investment from a company's dividend payments over the past 12 months.

Want to invest in AbbVie? 
Get the Kraken app

Eligible US clients can now invest in over 11,000 stocks and ETFs - commission-free* - directly in the Kraken app. Download it and get started.

Fictional stock
USD icon
USD
ABBV icon
ABBV

Only available to USA clients through the Kraken app
or Kraken Pro.

Explore other stocks

Most active

Explore the most-traded stocks today

Top gainers

Browse today’s biggest stock market winners

USDE icon
USDEW icon
LCFYW icon

LCFYW

Top losers

Compare the worst-performing stocks of 
the day

YOTAR icon

YOTAR

JDZG icon

JDZG

EVLVW icon

Want to learn more about equities?

Check out our Kraken Learn Center guides

Currently available in the U.S. only; may not be available in all states. Brokerage services are provided by Kraken Securities LLC, member FINRA/SIPC. Please view the firm’s profile, registration and background of our registered reps on https://brokercheck.finra.org/. Digital asset services offered by Payward Interactive, not a member of FINRA/ SIPC and not FDIC insured. This is not an offer, solicitation, inducement or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Kraken Securities is not registered. All trading involves risk, including loss of your investments. View full disclosures at: Equities Disclosures and Crypto Risk Disclosures.

*Other applicable fees may apply.